PureTech Health plc (OTCMKTS:PTCHF – Get Rating) saw a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 86,400 shares, a decline of 45.7% from the November 30th total of 159,100 shares. Based on an average daily volume of 8,300 shares, the short-interest ratio is presently 10.4 days.
PureTech Health Stock Performance
Shares of OTCMKTS:PTCHF traded up $0.28 during midday trading on Thursday, hitting $3.27. 25,181 shares of the stock were exchanged, compared to its average volume of 6,292. The business's 50-day moving average price is $3.05 and its 200 day moving average price is $2.70. PureTech Health has a 12 month low of $1.83 and a 12 month high of $4.14.
Get PureTech Health alerts:About PureTech Health
(Get Rating)
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and psychosis in Alzheimer's disease; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; an immunomodulation platform to treat chronic and acute inflammatory disorders; oral therapies based on defined consortia of bacteria is isolated from the human microbiome; and therapies to treat cognitive dysfunction associated with depression, multiple sclerosis, post COVID and ICU, and cancer related conditions.Recommended Stories
- Get a free copy of the StockNews.com research report on PureTech Health (PTCHF)
- 3 High-Yield Dividend Stocks to Hold for the Long Haul
- Cal-Maine Posts Record Quarter, Remain CALM Income Investors
- Tesla Stock: What the Bulls and the Bears Are Getting Wrong
- Big Health Care Stocks to Watch in the New Year
- The Top Three Stocks Analysts Say To Buy
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.